Case studies

Our case studies provide an in-depth examination of the solutions and innovations PATH and partners develop to address the world's most pressing health issues.

All case studies
33 Result s
  1. Anticipating the global risk posed by outbreaks of vaccine-derived polio, researchers accelerated the development of a novel oral polio vaccine (nOPV2) more genetically stable than its predecessor. Today, nOPV2 is driving down the number of outbreaks.